Skip to main content

RadNet, Inc.

corporate_fare Company Profile

RadNet, Inc.

RDNT·NASDAQ·Industrial Applications And Services·CIK 0000790526

Diagnostic Imaging Corp. is a leading national provider of diagnostic imaging services in the United States, based on its number of locations and annual imaging revenue. Established in 1985, the company's primary business segment focuses on delivering diagnostic imaging services. As of December 31, 2025, the company operated 418 imaging centers, either directly or through joint ventures with hospitals and health systems. These centers are located in Arizona, California, Delaware, Florida, Maryland, Virginia, New Jersey, Texas, and New York. The Imaging Centers segment offers physicians capabilities to diagnose and treat diseases and disorders, potentially reducing the need for invasive procedures and lowering patient care costs. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related procedures. Most centers provide multi-modality imaging services, which diversifies revenue, reduces exposure to reimbursement changes, and offers a single location for multiple procedures. Integral to the imaging center business is the Digital Health operating segment, which sells computerized systems for distributing, displaying, storing, and retrieving digital images. The company aims to achieve leading positions in regional markets through organic growth and acquisitions to leverage operational efficiencies. Its scale and density in selected geographies foster long-term relationships with key payors, radiology groups, and referring physicians. Center-level and regional operations teams manage local physician and payor relationships, ensure patient service standards, and maintain profitability. The company also provides training, standardized policies, and best practice sharing among physicians in its regional networks. Internationally, the majority-owned subsidiary, The HLH Imaging Group Limited, formerly known as Heart & Lung Imaging Limited, provides teleradiology services for remote image interpretation to providers within the United Kingdom's National Health Service.

RadNet, Inc. (NASDAQ:RDNT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for RDNT at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • RadNet Acquires AI Firm Gleamer, Becomes World's Largest Radiology Clinical AI Provider
  • RadNet Promotes Key Executives to CEO and COO Roles, Expands Leadership Team

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.04B
Net Income
-$18.65M
Diluted EPS
-$0.25
Op. Cash Flow
$298.82M
Operating Income
$61.99M
Cash & Equivalents
$767.22M
Total Debt
$1.09B
Debt / Equity
1.00×
Net Margin
-0.9%
Shares Outstanding
74.04M sh
Source: 10-K · filed 2026-03-02 · accession 0001628280-26-013337
$68.35 -1.95% today
52-week range · as of 2026-11-09 $50.82 – $85.84
Market cap
$5.49B
Volume
594.2K (0.9× avg)
3-mo avg 679K
Live data · 2026-11-22 08:22 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RDNT - Filings & News (Page 2)

RDNT
Mar 02, 2026, 5:45 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $69.81
Real-time Price: $68.35 info
Change: -$1.46 (-2%) info
Market Cap: $5.491B info
RDNT
Jan 09, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $78.20
Real-time Price: $68.35 info
Change: -$9.85 (-13%) info
Market Cap: $5.491B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets